Stay updated on Liraglutide Effect on Diastolic Dysfunction in Diabetes Clinical Trial

Sign up to get notified when there's something new on the Liraglutide Effect on Diastolic Dysfunction in Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Liraglutide Effect on Diastolic Dysfunction in Diabetes Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.4%
    Check dated 2024-07-23T14:29:17.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:07:29.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:08:08.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-27T10:00:06.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:53:52.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value on the web page has changed from 'Show more Show more Revision: v2.9.0' to 'Show less MedlinePlus Genetics related topics: Type 2 diabetes Drug Information available for: Liraglutide FDA Drug and Device Resources Show less Design Details Primary Purpose : Treatment Allocation : Randomized Interventional Model : Parallel Assignment Masking : Triple ( Participant Care Provider Investigator ) Arms and Interventions Participant Group/Arm Intervention/Treatment Active Comparator : Liraglutide arm Patients will be treated with liraglutide (up to 1.8 mg s.c. once daily). Total treatment period will be 18 weeks. Drug : Liraglutide Other Names: Victoza Placebo Comparator : Placebo arm Patients will be treated with placebo (up to equal to 1.8 mg drug dose s.c. once daily). Total treatment period will be 18 weeks. The study will be placebo-controlled with placebo as an add-on to conventional diabetes treatment. Thus, no patient will receive a sub-standard treatment. Drug : Placebo Primary Outcome Measures Outcome Measure Measure Description Time Frame Change in diastolic properties as assessed by CMR. LA passive emptying fraction (%) (before and after glycopyrolate) Measured in week 18 and compared to baseline. Change in diastolic properties as assessed by CMR. LV peak filling rate (ml/s) (before and after glycopyrolate) Measured in week 18 and compared to baseline. Secondary Outcome Measures Outcome Measure Measure Description Time Frame MRI indices of myocardial perfusion Measured in week 18 and compared to baseline. Echocardiographic indices of diastolic dysfunction Measured in week 18 and compared to baseline. Additional Relevant MeSH Terms Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Diabetes Mellitus Diabetes Mellitus, Type 2 Glucagon-Like Peptide-1 Receptor Agonists Hypoglycemic Agents Physiological Effects of Drugs Incretins Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Liraglutide Revision: v2.9.1.'
    Difference
    12%
    Check dated 2024-06-25T08:31:09.000Z thumbnail image

Stay in the know with updates to Liraglutide Effect on Diastolic Dysfunction in Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Liraglutide Effect on Diastolic Dysfunction in Diabetes Clinical Trial page.